MOJ
eISSN: 2379-6162
Submit manuscript...
Case Report Volume 13 Issue 2
Highest reported level of the CA 19-9 tumor marker in pancreatic cancer: case report
Alejandro Weber Sánchez, Pablo Weber Alavrez
Received: May 29, 2025 | Published: June 23, 2025
Citation: Weber-Sánchez A, Weber-Alvarez P. Highest reported level of the CA 19-9 tumor marker in pancreatic cancer: case report. MOJ Surg. 2025;13(2):46-47. DOI: 10.15406/mojs.2025.13.00292
Abstract
Pancreatic cancer is one of the malignancies with the worst prognosis, characterized by late diagnosis and high mortality. CA 19-9 is the most commonly used tumor marker for this disease, although its interpretation is limited and elevations are also observed in other benign conditions. Elevated serum CA 19-9 levels usually reflect the extent of the disease, and when combined with other tumor markers improve the diagnostic sensitivity. We here report the case of a patient with pancreatic cancer in whom CA 19-9 determination reached an extraordinary level, to our knowledge, one of the highest levels of this tumor marker reported in the medical literature.
Keywords: breast cancer, tumor markers, CA 19-9, pancreatic cancer, abdominal pain
©2025 Weber-Sánchez, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.